RN7SL89P

Across TCGA pan-cancer cohorts, RN7SL89P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL89P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RN7SL89P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL89P expression acts as an unfavorable survival marker, although some lineages such as LUAD and KIRP show a favorable association.

OV, ACC, and UCS are the cancer types where RN7SL89P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.410	0.560	<.001	108	view →
ACC	OS	Tertile	All	0.532	0.913	<.001	108	view →
UCS	OS	Tertile	III,IV	0.145	0.605	.005	90	view →
CHOL	OS	Tertile	All	0.019	0.800	<.001	54	view →
KICH	OS	Tertile	II,III,IV	0.070	0.828	<.001	45	view →
THCA	OS	Tertile	III,IV	0.850	0.989	<.001	42	view →
LUAD	OS	Tertile	All	0.637	0.343	.028	27	view →
KIRC	DFS	Tertile	All	0.476	0.680	.006	22	view →
KIRP	DFS	Tertile	III,IV	0.867	0.336	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL89P–OV (DFS)

Open the OV breakdown →